ライフサイエンスコーパス: participant

1 te Track-On HD cohort (74 pre-HD, 79 control participants).

2 regularly cause large losses to marketplace participants.

3 Evidence of CKD was found in 18,034 (6.4%) participants.

4 ychotherapy for FND with at least five adult participants.

5 al and functional brain MRI in 108 Barcelona participants.

6 lved in attending can exclude many potential participants.

7 Italy, with three groups of approximately 50 participants.

8 hat preserve the individual-level privacy of participants.

9 ed an SVR12 rate of >95% in NS5A-experienced participants.

10 n up to 440,000 UK Biobank and 54,451 CKDGen participants.

11 scalated, aiming to colonize at least 70% of participants.

12 ains to be determined with a large cohort of participants.

13 tions, 346 (31.9%) were underreported by the participants.

14 ampus, performing the same task as the human participants.

15 an deviation [MD] >-5 dB) and normal control participants.

16 h comparable measurement time points in STAY participants.

17 612-0.776) and classified correctly 62.4% of participants.

18 erative rupture were reported in 113 of 1088 participants (10.4%) and 34 of 1088 participants (3.1%),

19 9 years) and 23 matched healthy control (HC) participants (11.0 +/- 3.3 years) before participants wi

20 In the BE-reactive comparator group, 7 of 39 participants (17.9%) achieved SU.

21 methods in a multinational study (n = 4,098 participants, 19 countries, 13 languages), adjusting onl

22 articularly with the highest dose, and three participants (21%) in the 250-mug dose group reported on

23 -blind placebo-controlled trial enrolled 252 participants (210 vaccine/42 placebo; median age 23 year

24 Twenty (55.6%) MR OA-using participants, 25 (69.4%) BP OA-using participants, and 1

25 Samples were collected from 550 participants (298 cases and 252 controls) according to i

26 of 1088 participants (10.4%) and 34 of 1088 participants (3.1%), respectively.

27 ively phenotyped developmental sample of 345 participants (312 healthy and 33 with clinical depressio

28 A total of 36 participants (37.5%) in the vitamin D3 group and 33 (34.

29 Almost half of participants (45.2%) reported a pre-surgery history of s

30 Nearly half the participants (49%) had had no angina during the month be

31 Of the 505 intervention participants, 491 (97%) received the Step it Up interven

32 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were inclu

33 Most participants (76.4%) accessed information mainly via soc

34 The vast majority of participants (84% at admission and 95% at discharge) too

35 Of 1893 participants (844 former cricketers), 16.9% reported han

36 DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study of the predic

37 ight changes from AIDS Clinical Trials Group participants (A5001 and A5322).

38 t SARS-CoV-2 were detected in 32 (91%) of 35 participants after a single dose when measured in MNA(80

39 Data from 10,713 dentate participants aged >=30 years in NHANES 2009-2014 were us

40 oimaging in a longitudinal sample of n = 146 participants aged 12-30.

41 e and vascular dementia, analyzing data from participants aged 40 years or older in the National Heal

42 Participants (aged 18-65 years), who were HIV-uninfected

43 esponses were evaluated at month 6.5 for all participants and at months 12, 12.5, and 18 for a random

44 sol, K10 scores, and fat intake among female participants and athletes were discovered.

45 on stool and saliva samples of normoglycemic participants and individuals with prediabetes or diabete

46 We masked participants and investigators to treatment allocation t

47 quine estrogens (CEE) among posthysterectomy participants and of these same estrogens plus medroxypro

48 elations in the delay suffered by both event participants and other citizens doing their usual travel

49 milarities and differences between different participants and symptoms, our multi-task learning model

50 A-using participants, 25 (69.4%) BP OA-using participants, and 16 (44.4%) participants using both OAs

51 19, identified from a cohort of nearly 5,300 participants, and found that 26 of them (81%) had altera

52 etween experience and reportability, whereby participants appear able to encode stimuli into working

53 Here, participants associated pairs of faces in two conditions

54 e for analysis from 614 (77%), and 561 (71%) participants at diagnosis and at end of induction, respe

55 In 8,935 participants at the baseline (1996-1998) from the Athero

56 um transaminases were retrieved from 444,642 participants, available in the United Kingdom biobank.

57 used machine-learning algorithms to classify participants based on psychosocial, neural, or both (neu

58 ue modulation was related to the strength of participants' behavioral VDAC effect and persisted into

59 Understanding participant behaviour could support better use of the da

60 We tracked participants' beliefs and found no difference in the spe

61 rmalized fronto-striatal connectivity in TRD participants but disrupted it in HVs independently of in

62 ach centre not involved in the management of participants' care, and monitored by an independent comm

63 We randomly allocated participants centrally (1:1) to either surveillance or f

64 impulsivity and acute stress exposure affect participants' choice behavior and decision speed in a tw

65 n4 and subcortical amyloid-beta may identify participants closest to MCI for secondary prevention tri

66 eat analysis revealed that the proportion of participants commencing treatment in the primary care ar

67 Eighty-seven (86%) participants completed 8 weeks of treatment.

68 Participants completed all study procedures at home with

69 Participants completed BREASTChoice in about 27 minutes.

70 e intention-to-treat analysis set, after all participants completed the month 15 visit.

71 Sixty participants completed the study.

72 We performed a two-stage individual participant data (IPD) analysis comparing participants w

73 the vast majority of right language dominant participants demonstrated a completely mirrored brain or

74 address these unknowns using a cohort of 57 participants diagnosed with Alzheimer's disease (18 with

75 We compare participants diagnosed with Major Depressive Disorder (M

76 ing follow-up through 2014, a total of 8,354 participants died of pancreatic cancer.

77 ng up to 21 years of follow-up, 30,389 (38%) participants died, corresponding to 22 deaths per 1,000

78 10 with a lesion outside PFC and 10 healthy participants (each group included both females and males

79 n the bronchoalveolar lavage fluid (BALF) of participants enrolled in the SubPopulations and InteRmed

80 wabs to detect S. aureus were collected from participants, environmental surfaces, and pets; incident

81 We found that participants exhibited remarkable inaccuracy in identify

82 ences in metabolic outcomes were apparent in participants following self-selected diets without inten

83 city in AD participants was lower than in ED participants for cpCD (0.32 [95% CI, 0.11-0.64] vs. 0.83

84 en April 6 and May 9, 2020, we enrolled 2766 participants from 1339 households, with a demographic di

85 In Malawi, 236 participants from the Advancing Cryptococcal Meningitis

86 me-wide association studies in up to 215,551 participants from the Million Veteran Program (MVP) were

87 This study included participants from two National Health Service (NHS) Trus

88 Participants generated and matched elbow torques when th

89 At end-induction, 98.8% of evaluable participants had at least a PR.

90 the primary efficacy analysis (ie, when all participants had completed 48 weeks and 50% had complete

91 All participants had device interrogations performed before

92 After 12.8 y (median), 6378 participants had experienced a CHD event.

93 2.1 mL/wk (IQR: 198.8-1416.4 mL/wk), and 233 participants had hyperuricemia.

94 Eligible participants had information about self-reported depress

95 About half of the participants had symptom networks that were sparse after

96 At 5 follow-up visits in participants' homes, swabs to detect S. aureus were coll

97 Compared with normotensive ARIC participants, IDH by the 2017 ACC/AHA definition was not

98 ll, outside of the cell itself, is an active participant in shaping plant cells.

99 Water and lipids are key participants in many biological processes, but there are

100 eloped using eligible female US and Canadian participants in the Childhood Cancer Survivor Study (CCS

101 For participants in the highest aMED score category, the ris

102 For example, participants in the highest versus lowest steps quartile

103 Participants in the initial sample included 840 trauma-e

104 Following randomisation, 149 (2%) of 6983 participants in the intervention group and 143 (2%) of 6

105 Twelve (4.3%) participants in the intervention group and 7 (2.4%) in t

106 Among 1654 participants in the intervention group who swallowed the

107 was between 13% and 41% lower compared with participants in the lowest score (pooled HR: 0.72, 95% C

108 We included 159 randomized participants in the modified intention-to-treat analysis

109 Participants in the MT group showed lower activity in th

110 the intervention group and 143 (2%) of 6531 participants in the usual care group, on further scrutin

111 Participants included 67,807 individuals with a diagnosi

112 Among the 51 761 participants included in this analysis, the mean (SD) ag

113 Most participants including healthy controls and ACS patients

114 lyses for 15 hematological traits in 746,667 participants, including 184,535 non-EUR individuals, we

115 With increasing speed differences participants increased their preferred value of step tim

116 The median age of enrolled participants is 21 years (range 0-93 years).

117 posure linear mixed-effects regressions with participant-level random intercept to identify significa

118 A generalized linear mixed model with a participant-level random intercept was used to estimate

119 tters or more in the intervention eye, and 3 participants lost more than 15 letters by month 1.

120 Participants made repeated choices between harmful and s

121 Results Seventeen participants (mean age +/- standard deviation, 13 years

122 Among 3891 participants (mean age 65 +/- 11 y; 55% women; 35% nonwh

123 Among the 2,264 participants (mean age = 62.6 years), the geometric mean

124 Results A total of 171 participants (mean age, 69 years +/- 8; 111 men) were ev

125 Prior to treatment, participants' microbiomes were dissimilar from the RBX74

126 DESIGN, SETTING, AND PARTICIPANTS: Multicenter randomized double-blind sequen

127 DESIGN, SETTING, AND PARTICIPANTS: Multicenter, noninferiority, point-of-care

128 ne mental health survey taken by a subset of participants (n = 157,366) in the UK Biobank.

129 In PESA participants (n = 4,184 subjects free of cardiovascular

130 Overall, 57.6% of participants (n = 571) intended to be vaccinated, 31.6%

131 dults attending a diabetes centre in the UAE.Participants (N = 973) with different weight and glucose

132 Neither participants nor investigators were masked to dose alloc

133 Participants not on anticoagulation or DAPT before the p

134 Only HIV-negative or HCV-negative participants not on medication assisted treatment (MAT)

135 We conducted participant-observation and semi-structured interviews a

136 and visuomotor learning in 20 young healthy participants of both sexes.

137 on (IR) and associative recall (AR) in human participants of both sexes.

138 t MG was identified in the baseline serum of participants of RIISC.

139 les from 405 HIV-infected and 111 uninfected participants of the Copenhagen Comorbidity in HIV Infect

140 The study population consisted of 3079 participants of the Northern Finland Birth Cohort 1966 w

141 We sorted all participants of the Swiss HIV Cohort Study (SHCS) with a

142 y improved LS and whole body BMD compared to participants on vitamin D/calcium supplementation and ex

143 DESIGN, SETTING, AND PARTICIPANTS: Open-label, randomized clinical trial cond

144 s increasing, many exclude pregnant women as participants or do not address pregnancy.

145 u217 did not change in amyloid-beta-negative participants, or in patients with mild cognitive impairm

146 Each participant performed this task both alone and in a shar

147 All participants performed a 40-minute exercise session twic

148 A second group of participants performed a reaching task under a visuomoto

149 The participants performed an incremental exercise test to v

150 ing endogenous or exogenous attention, while participants performed the same orientation discriminati

151 The other half of the participants performed the task without any attention ma

152 In Protocol 2, participants performed two exercise bouts in which muscl

153 low-up time of 62.5 months, 564 of the 3,478 participants progressed to kidney failure, and 803 died.

154 n follow-up of 5.4 (IQR 5.1-5.9) years, 8828 participants provided a baseline and one or more follow-

155 al digital subtraction angiography decreased participants' radiation exposure while preserving diagno

156 DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial at 39 DRCR Retin

157 el extension (part B), during which time all participants received clazakizumab.

158 RP), and both hsCRP and IL-6 decreased among participants receiving canakinumab compared with the pla

159 extracts (0%-36%); instead, over 40% of all participants recognized CCD-bearing components.

160 e 3-month cumulative SSTI: 23 of 212 (10.8%) participants reported SSTI in Household Approach househo

161 Approach households, while 23 of 236 (9.7%) participants reported SSTI in Personalized Approach hous

162 Participants reported upper and lower ARIs on monthly qu

163 Participant-reported local reactions (LRs) and systemic

164 Participants reporting urogenital symptoms had a signifi

165 DESIGN, SETTING, AND PARTICIPANTS: Representative sample of US adults aged at

166 ensitivity, but increased the speed at which participants responded to visual stimuli of low spatial

167 Participants reviewed items of the decision-making proce

168 , we show that the model accurately predicts participants' search behavior in different environments.

169 No participants showed improvement of 15 letters or more in

170 Relative to the spatial domain, participants showed reduced levels of uncertainty-direct

171 tions for the first time, with British/Irish participants showing increased mouth scanning and the Ja

172 Participants' socioeconomic status and clinical, sanitat

173 By contrast, participants succeeded in discriminating between the TOM

174 e beacons, we did not find any evidence that participants successfully exploited the prior distributi

175 Yields varied widely among participants; summed yields ranged from 0.33 to 0.93.

176 haracteristics, younger, healthier, Hispanic participants tended to have a higher likelihood of compl

177 and varicella were lower in postchemotherapy participants than controls after adjusting for previous

178 nd genomic data from over 100,000 UK Biobank participants, the authors sought to systematically scree

179 MESA (Multi-Ethnic Study of Atherosclerosis) participants, the cross-sectional (exam 1) and longitudi

180 Among 1,737 female and 1,563 male participants, the overall prevalence of M. genitalium in

181 DESIGN, SETTING, AND PARTICIPANTS: The Vein of Marshall Ethanol for Untreated

182 We exposed human participants to auditory cues that predicted the likely

183 n is the self-generated activity that allows participants to learn new sensorimotor schemes.

184 ent and local currencies while requiring all participants to respond to all items.

185 tor addition models captured the tendency of participants to under-encode guided sides of the triangl

186 ically detect high-risk phenotypes of LVH in participants undergoing CAC-CT, without the need for add

187 All participants underwent a complete multimodal imaging ass

188 Participants underwent an 8-wk low-calorie diet (LCD) re

189 Twenty-four hours after exposure, participants underwent bronchoscopy to collect epithelia

190 Participants underwent DCB angioplasty or conventional b

191 Study participants underwent macular 3- x 3-mm OCTA scans with

192 A total of 5713 participants underwent randomization, and the mean follo

193 All study participants underwent standardized diffusion-weighted M

194 Participants underwent standardized systemic and ocular

195 Participants (University of Michigan glaucoma patients a

196 4%) BP OA-using participants, and 16 (44.4%) participants using both OAs had significant REI reductio

197 PM2.5 exposure during pregnancy for each participant was estimated by means of land-use regressio

198 One eye per participant was included.

199 Sensitivity at 95% specificity in AD participants was lower than in ED participants for cpCD

200 ach of 39 glaucoma and 31 age-matched normal participants was scanned using 4.5-mm OCTA scans centere

201 The present substudy, including 30 participants, was prespecified as part of the Mineraloco

202 Participants were 479 registered nurses (working as staf

203 Participants were 55 to 90 years with GA secondary to ag

204 The aggregate demographic details for study participants were a mean age of 43.80 years, 47% male an

205 Participants were aged 30 to 65 years, dentate, periodon

206 Both before and after learning, participants were also scanned while viewing indirectly

207 Participants were asked to complete the 26-item World He

208 l and an approximate Bayesian model in which participants were assumed to attend (and learn about) on

209 Participants were aware of study group allocation.

210 Investigators and participants were aware of treatment allocation.

211 Participants were classified into groups according to th

212 Inside the scanner, participants were cued which task to perform and then se

213 Participants were employees of a large hospital in Bosto

214 Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548

215 All participants were examined with a comprehensive ophthalm

216 Participants were exposed to three different blinded dos

217 dy collected data between 2006 and 2010, and participants were followed up until 2016.

218 hs and the missing weights for the remaining participants were imputed.

219 ian mean deviation, -2.31 dB) and 65 control participants were included in the study.

220 cially disfigured and 74 facially disfigured participants were included.

221 Most participants were male (645 [84%] of 766) and white (560

222 Participants were members of the Environmental Risk Long

223 In all studies, participants were presented with scenarios in which an e

224 In one experiment, participants were provided with a pre-specified cognitiv

225 Participants were randomized (1:1 ratio) to a strategy o

226 Participants were randomized 1:1 to receive 2 intramuscu

227 Participants were randomized 2:1 to FAi or sham (injecti

228 Participants were randomized to 1 of 4 sunscreen product

229 e 2012 through February 2018, a total of 170 participants were randomized to receive 6 monthly inject

230 Study participants were randomized to receive 960 mg of oral c

231 parallel-group, double-blind clinical trial, participants were randomized to receive either 150 mg/d

232 629 participants were randomly assigned and treated in study

233 20 099 participants were randomly assigned and vaccinated betwe

234 Participants were randomly assigned into 5 weight loss m

235 Participants were randomly assigned to once-daily oral f

236 time of percutaneous coronary intervention, participants were randomly assigned to prospective rapid

237 ek lead-in period of cognitive training, 100 participants were randomly assigned to receive either vo

238 A total of 1458 participants were randomly selected from The Malaysian C

239 Healthy adult participants were recruited and randomized to (I) IDA al

240 Seventy-seven participants were recruited between April 14, 2011, and

241 this open-label, single-arm, phase 3 trial, participants were recruited from 24 academic sites in th

242 The participants were submitted to a full-mouth periodontal

243 Eligible participants were women aged 18 years or older with Inte

244 Average age was 73 +/- 8 years, and 52% of participants were women.

245 A total of 100 eyes (62% were female participants) were evaluated.

246 11 women and 9 men, for a total of 20 participants, were included in the analysis.

247 d 33 cohort studies, with a total of 179 230 participants, were included.

248 se when measured in MNA(80) and in 35 (100%) participants when measured in PRNT(50).

249 e projects can provide numerous benefits for participants while educating and connecting professional

250 ndary efficacy endpoint of the proportion of participants who achieved this concentration by week 96,

251 ar with BE and egg OIT, but more frequent in participants who are BE-reactive.

252 Dosing symptom frequency in participants who are BE-tolerant was similar with BE and

253 hort died; the median baseline CD4 count for participants who died was 11 cells per muL.

254 Among the 840 participants who enrolled (mean age, 59.3 years [SD, 8.6

255 The mortality rate among the 835 participants who had initiated ART was 1.9 per 100 perso

256 Considering participants who had moderate and severe symptoms (23 to

257 is concentration by week 96, assessed in all participants who received at least one dose of any study

258 Safety was assessed in all participants who received at least one dose of study dru

259 Compared to 31 participants who used neither agonists nor antagonists,

260 who used neither agonists nor antagonists, 5 participants who used opioid agonists (without antagonis

261 ematic PTSD assessments; and included >= 450 participants who were current residents of an SSA countr

262 Of 40 participants who were randomized, 17 dipyridamole and 18

263 questionnaire and administered to the study participants who were recruited with a multi-stage sampl

264 Participants, whose primary care physician considered th

265 At enrollment (2017-2018), 1,493 participants with 6 or fewer cycles of attempt time were

266 ings were observed in analyses restricted to participants with a history of osteoarthritis.

267 plus medroxyprogesterone acetate (MPA) among participants with an intact uterus were carried out at 4

268 In an open label clinical trials, participants with ASD were administered a single infusio

269 esults: The study population included 53,654 participants with asthma exacerbation.

270 400 copies/mL) was independently lower among participants with baseline CD4 count >=500 cells/uL (3.3

271 ls and Methods Healthy individuals and study participants with CF were prospectively enrolled between

272 semispinalis cervicis) in a small cohort of participants with chronic whiplash associated disorders

273 aryngeal or oropharyngeal specimens from 251 participants with COVID-19 symptoms (<=7 days from sympt

274 After excluding participants with diabetes mellitus and quality control,

275 r mortality (HR, 1.66 [CI, 1.07 to 2.57]) in participants with diabetes.

276 ase progression over a wide range of ages in participants with DMD.

277 Cognitive impairment in participants with Down syndrome was classified with the

278 Participants with estimated glomerular filtration rate (

279 Participants with GDF-15 values in the highest quartile

280 Among participants with HIV infection, 36/108 (33%) had incide

281 The percentage of participants with local or systemic adverse events was s

282 The primary outcomes were the proportion of participants with major depression and function scores a

283 National Alzheimer's Coordinating Center on participants with mild cognitive impairment at baseline

284 Participants with mild MS showed significantly better BC

285 ics of nilotinib, and measured biomarkers in participants with mild to moderate dementia due to Alzhe

286 vidence of a difference in the proportion of participants with mRS 0-3 at 90 days according to treatm

287 HC) participants (11.0 +/- 3.3 years) before participants with OCD completed a course of cognitive-be

288 rvastatin was compared with placebo in 4,731 participants with recent stroke or transient ischemic at

289 There were 90 ART-experienced participants with resistance to both efavirenz and lamiv

290 Participants with rhinitis from 2 multicenter European c

291 New loss of smell was more prevalent in participants with SARS-CoV-2 antibodies, compared with t

292 Participants with stable coronary artery disease underwe

293 al participant data (IPD) analysis comparing participants with subclinical hypo- or hyperthyroidism v

294 48, 95% CI 1.54-3.95), and the proportion of participants with SVR12 was significantly higher in the

295 cal neural activity changes when three human participants with tetraplegia observe, imagine, and atte

296 In a subset of 77 906 participants with up to 5 web-based 24-hour-recall food

297 Participants with virologic failure and anticipated anti

298 18 months after the INSTI switch/add in SWAD participants, with comparable measurement time points in

299 Of 2294 MESA Lung participants without prevalent COPD, 98 (4.3%) had incid

300 For participants without SILs at baseline, we estimated the